share_log

OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences

OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences

OTR Acquisition Corp.報告與科美拉生命科學公司的交易有關的S-4註冊聲明的保密提交
Benzinga Real-time News ·  2022/02/04 08:06

OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))), a publicly traded special purpose acquisition company (SPAC), today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Comera Life Sciences, Inc.

Otr Acquisition Corp.(納斯達克代碼：OTRAU，OTRA and OTRAW)是一家上市的特殊目的收購公司(SPAC)，今天宣佈向美國證券交易委員會(“美國證券交易委員會”)保密提交一份S-4表格註冊聲明草案(下稱“註冊聲明”)，涉及其先前宣佈的與Comera生命科學公司擬議的業務合併。

This press release features multimedia. View the full release here:

這份新聞稿以多媒體為特色。點擊此處查看完整版本：

In addition, the investor call with Comera and OTR has been rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST (from previous date and time of Friday, Feb. 4 at 8:30 a.m. EST) to discuss the proposed business combination. An audio webcast of the event will be available on the OTR Investor Relations website at

此外，與Comera和OTR的投資者電話會議已重新安排到2月8日星期二上午8：30。東部時間(來自之前的日期和時間，2月4日，星期五，上午8：30EST(EST：行情)討論擬議的業務合併.此次活動的音頻網絡直播將在OTR投資者關係網站上提供，網址為：

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論